We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-15.73%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$10.8B
AUM Growth
-$6.75B
Cap. Flow
-$3.21B
Cap. Flow %
-29.71%
Top 10 Hldgs %
32.15%
Holding
417
New
16
Increased
59
Reduced
212
Closed
127

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$312M
2
CFLT
Confluent
CFLT
+$124M
3
COIN icon
Coinbase
COIN
+$96.6M
4
NVDA icon
NVIDIA
NVDA
+$93.6M
5
NET icon
Cloudflare
NET
+$90.7M

Sector Composition

Rank Sector Weight
1 Technology 33.94%
2 Consumer Discretionary 22.39%
3 Healthcare 17.63%
4 Communication Services 10.7%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNTM
251
DELISTED
Pontem Corporation
PNTM
$945K 0.01%
96,289
-173,912
-64% -$1.7M
UPST icon
252
Upstart Holdings
UPST
$2.48B
$913K 0.01%
8,371
+3,095
+59% +$357K
UBER icon
253
Uber
UBER
$146B
$889K 0.01%
24,910
-20
-0.1% -$719
VCYT icon
254
Veracyte
VCYT
$3.29B
$882K 0.01%
32,009
-41,911
-57% -$1.2M
ILMN icon
255
Illumina
ILMN
$32.1B
$868K 0.01%
2,554
-4,290
-63% -$1.45M
VIRX
256
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$868K 0.01%
182,396
-32,170
-15% -$96.9K
SHLS icon
257
Shoals Technologies Group
SHLS
$1.21B
$860K 0.01%
50,463
-73,305
-59% -$1.27M
NYXH
258
Nyxoah
NYXH
$160M
$858K 0.01%
44,849
-2,023
-4% -$40.7K
WDAY icon
259
Workday
WDAY
$46B
$812K 0.01%
3,390
-39,094
-92% -$9.32M
SANA icon
260
Sana Biotechnology
SANA
$922M
$692K 0.01%
+83,775
New +$677K
CURV icon
261
Torrid Holdings
CURV
$220M
$653K 0.01%
107,730
-264,646
-71% -$2.25M
CCCC icon
262
C4 Therapeutics
CCCC
$416M
$646K 0.01%
+26,628
New +$647K
STAA icon
263
STAAR Surgical
STAA
$1.13B
$588K 0.01%
7,356
+7,090
+2,665% +$528K
SRPT icon
264
Sarepta Therapeutics
SRPT
$2.17B
$586K 0.01%
7,504
-304
-4% -$23.3K
SGHT icon
265
Sight Sciences
SGHT
$445M
$573K 0.01%
49,537
+15,688
+46% +$241K
OPEN icon
266
Opendoor
OPEN
$2.59B
$500K ﹤0.01%
59,747
-568
-0.9% -$5.28K
RARE icon
267
Ultragenyx Pharmaceutical
RARE
$1.31B
$490K ﹤0.01%
6,751
-7,283
-52% -$507K
ASTS icon
268
AST SpaceMobile
ASTS
$17.6B
$489K ﹤0.01%
48,978
-72
-0.1% -$529
SMAR
269
DELISTED
Smartsheet Inc.
SMAR
$462K ﹤0.01%
8,437
-2,841
-25% -$162K
CMG icon
270
Chipotle Mexican Grill
CMG
$44.7B
$457K ﹤0.01%
14,450
+13,300
+1,157% +$401K
YETI icon
271
Yeti Holdings
YETI
$2.91B
$454K ﹤0.01%
7,562
+2,371
+46% +$153K
EB
272
DELISTED
Eventbrite
EB
$447K ﹤0.01%
30,274
-32,260
-52% -$478K
EWCZ
273
DELISTED
European Wax Center
EWCZ
$430K ﹤0.01%
14,546
+3,504
+32% +$91.1K
SHEN icon
274
Shenandoah Telecom
SHEN
$641M
$420K ﹤0.01%
17,819
+4,370
+32% +$98.6K
SLGC
275
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$389K ﹤0.01%
48,545
-21,901
-31% -$193K

Similar funds

Gilder Gagnon Howe & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Gilder Gagnon Howe & Co held 417 positions worth $10.8B, down 38% from $17.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $3.21B in Q1 2022, closing 127 positions and reducing 212 holdings. Its most notable exit was Chegg, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Palo Alto Networks worth $26.8M.

  • Gilder Gagnon Howe & Co's largest Q1 2022 buy was Palo Alto Networks: 258,054 shares worth $26.8M.
  • Gilder Gagnon Howe & Co added most to Xometry in Q1 2022, an estimated $17.2M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2022 reduction was Tesla, cutting an estimated $312M.
  • Gilder Gagnon Howe & Co fully exited Chegg in Q1 2022, selling an estimated $44.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $10.8B portfolio in Q1 2022.
  • Gilder Gagnon Howe & Co opened 16 new positions and closed 127 in Q1 2022.
  • Gilder Gagnon Howe & Co's portfolio value fell 38% quarter-over-quarter to $10.8B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2022, filed 16 May 2022.